FAST NEWS: Drug Discovery Business Helps Viva Biotech Swing Back to Profit
The latest: Viva Biotech Holdings (1873.HK) released a positive profit forecast, saying it posted a net profit of 300 million yuan ($48.2 million) or more last year, reversing a loss…
RELATED ARTICLES
-
Bye bye Bossini? Faded clothing retailer gets a buyout offer
0933.HK 0592.HK 2331.HK -
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
Cancer drug maker Biostar shines on Hong Kong market debut
2563.HK
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Trade-in ‘chic’ helps boost ATRenew to first operating profit
RERE.US
